Skip to content
Nonprofiteer
← ALS CURE PROJECT INC

Form 990 for tax year 2022

Filed by ALS CURE PROJECT INC.

Totals

Total revenue
$158,344
Total expenses
$245,563
Contributions and grants received
$143,790
Grants paid
$240,000
Program service revenue
$0
Investment income
$0
Other revenue
$14,554
Total assets, end of year
$178,157
Total liabilities, end of year
$0
Net assets or fund balances, end of year
$178,157
Program services expenses (Part IX)
$240,000
Management and general expenses
$1,535
Fundraising expenses
$4,028
Program service expenses (Part III)
$240,000

Program services were 97.7% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1c · Fundraising events

    $143,790

  • 8a · Fundraising events: gross income

    $330,687

  • 8a · Fundraising events: contributions included on line 1c

    $143,790

  • 8b · Fundraising events: direct expenses

    $316,133

  • 8c · Net income from fundraising events

    total $14,554

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $240,000 · program services $240,000

  • 2 · Grants to domestic individuals

    total $0

  • 3 · Grants to foreign organizations and individuals

    total $0

  • 4 · Benefits paid to or for members

    total $0

  • 5 · Compensation of officers, directors and key employees

    total $0

  • 6 · Compensation of disqualified persons

    total $0

  • 7 · Other salaries and wages

    total $0

  • 8 · Pension plan contributions

    total $0

  • 9 · Other employee benefits

    total $0

  • 10 · Payroll taxes

    total $0

  • 11a · Fees: management

    total $0

  • 11b · Fees: legal

    total $0

  • 11c · Fees: accounting

    total $0

  • 11d · Fees: lobbying

    total $0

  • 11f · Fees: investment management

    total $0

  • 11g · Fees: other

    total $0

  • 12 · Advertising and promotion

    total $0

  • 13 · Office expenses

    total $1,486 · fundraising $1,486

  • 14 · Information technology

    total $2,542 · fundraising $2,542

  • 15 · Royalties

    total $0

  • 16 · Occupancy

    total $0

  • 17 · Travel

    total $0

  • 18 · Travel or entertainment for public officials

    total $0

  • 19 · Conferences, conventions and meetings

    total $0

  • 20 · Interest

    total $0

  • 21 · Payments to affiliates

    total $0

  • 22 · Depreciation, depletion and amortization

    total $0

  • 23 · Insurance

    total $1,535 · management and general $1,535

  • 24e · All other expenses

    total $0

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $233,276 · end of year $178,157

  • 9 · Prepaid expenses and deferred charges

    beginning of year $32,100

  • 27 · Net assets without donor restrictions

    beginning of year $265,376 · end of year $133,157

  • 28 · Net assets with donor restrictions

    end of year $45,000

Mission and programs · 2022

Mission

This year the ALS Cure Project has funded multi-gene modeling at Stanford University and Sheffield University as funding research utilizing Sierram, the Lawerence Livermore Natonal Lab supercomputer, in multi-modal longitudinal modeling and physics-based modeling of TDP-43 protein aggregates which are present in over 95 of ALS cases.

Activities or mission (Part I)

The specfic purpose of the Organization shall include without limitation, to lead scientific research focused on the identification of Amyotrophic Lateral Scierosis ALS bio-markers and disease mechanism

  • ALS Cure Project continued to fund the Physics based modeling project using the worlds fastest supercomputer at Lawerance Livermore Lab to help idenity and understand the ALS disease mechanism. The initial focus will be on the formation of the aberrant TAR DNA- binding protien 43 TDP-43 inclusions or cluster that transition into pathological, amyyloid-like fibrils

    Expenses $90,000

  • ALS Cure Project funded a pilot program to evaluate the applicability of LLNLs Brain-on-chip platform to support an in vitro ALS model recapitulating key disease phenotype. This capability can then be used to probe neuronal function as a readout of efficacy to therapeutic compounds, including those being developed at Prosetta Biosciences.

    Expenses $100,000

  • The ALS Cure Project seeded 2 research project Barrow Neuro and Triparite selected from the ALS Innovation Symposim held virtual on November 17th and December 1stof 2021 that included 115 international ALS researchers from 10 nations where participants worked collaboratively in workshop styled breakouts to create the symposiums product. The event was also co-sponsored by Mitsubishi Tanabe Pharma America MTPA

    Expenses $50,000

As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Mike Piscotty

    President

    Total calculated
    $0
    Hours/week
    10
  • Stephen Piscotty

    VIce President

    Total calculated
    $0
    Hours/week
    1
  • Toni Eslick

    Secretary

    Total calculated
    $0
    Hours/week
    6
  • James Gilbreth

    Fund Raising Director

    Total calculated
    $0
    Hours/week
    6
  • Barron Wesenberg

    Treasurer

    Total calculated
    $0
    Hours/week
    3
  • Andrew Woodward

    IT Communications Director

    Total calculated
    $0
    Hours/week
    3
  • Phil Green

    Corporate Sponsorship Director

    Total calculated
    $0
    Hours/week
    3
  • Jim Poole

    Strategic Partnership Director

    Total calculated
    $0
    Hours/week
    3

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

Provenance

Return type
form_990
Tax year
2022
Filed
18 April 2023
IRS schema version
2022v5.0
Source object
202311099349300101

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.